Related Experiment Videos
Stevens-Johnson syndrome associated with Malarone antimalarial prophylaxis
Michael Emberger1, Arno Michael Lechner, Bernhard Zelger
1Department of Dermatology, General Hospital Salzburg, 5020 Salzburg, Austria. M.Emberger@lks.at
Summary
Stevens-Johnson syndrome (SJS), a severe skin reaction, has not been previously linked to Malarone (atovaquone and proguanil hydrochloride). A case report details SJS in a patient using Malarone for malaria prevention, highlighting a potential adverse drug reaction.
Area of Science:
- Pharmacology
- Dermatology
- Infectious Diseases
Background:
- Malarone, a combination of atovaquone and proguanil hydrochloride, is widely used for malaria prophylaxis and treatment.
- Stevens-Johnson syndrome (SJS) is a severe, potentially life-threatening mucocutaneous reaction often triggered by medications.
Observation:
- A 65-year-old patient developed SJS with characteristic clinical and histopathological features.
- The adverse reaction was temporally associated with the use of Malarone for malaria prophylaxis.
Findings:
- This case represents the first reported instance of SJS as an adverse reaction to Malarone.
- The findings suggest a causal link between Malarone use and the development of SJS.
Implications:
- Physicians should be aware of the potential for Malarone to cause SJS, a severe cutaneous adverse drug reaction.
- Malarone should be considered among the drugs capable of inducing SJS, necessitating careful patient monitoring.